Skip navigation.
Home
Tue Feb 9 08:08:00 2010 | [Write for us] | [Subscribe to RSS] | [Advertise with us] [Editor's Blog]

FDA approves GSK’s platelet-boosting drug Promacta

Philadelphia, November 21: The U.S. Food and Drug Administration on Thursday granted accelerated approval to a new platelet-boosting drug, Promacta, for treating chronic immune thrombocytopenic purpura (ITP) disorder in adults.

Manufactured by British drugmaker GlaxoSmithKline Plc, the drug is the first oral thrombopoietin (TPO) receptor agonist approved to treat bleeding problems caused by a rare immune systemdefine disorder.

Chronic ITP is a disorder marked by low platelet count (thrombocytopenia) in the blood. As the blood platelets induce blood clotting, a very low platelet count leads to bleeding diathesis (the unusual susceptibility to bleed) and purpura (appearance of red or purple discolorations on the skin). The bleeding severity ranges from mild to lethal. An estimated 60,000 individuals are diagnosed with chronic ITP in the United States.

The drug, Promacta, is an oral, non-peptide thrombopoietin receptor agonist that helps stimulate the proliferation and differentiation of megakaryocytes, the bone marrow cells that induce blood platelets.

The approval is based on the results of the clinical trial that involved 114 adult patients with chronic ITP and baseline platelet counts of less than 30,000/microliter. While 76 patients were randomly assigned to receive a 50mg once-daily dose of Promacta (eltrombopag olamine) for six weeks, 38 were put on a placebo pill. However, the Promacta dose could be increased to 75mg in patients not responding to initial three weeks of treatment.

Results of the study revealed that Promacta when administered at a 50-75mg once-daily dose was significantly effective in increasing the platelet count. It also helped reduce the bleeding in adult patients with chronic idiopathic thrombocytopenic purpura (ITP).

However, as the drug may cause hepatotoxicity (chemical-driven liver damage) patients on active Promacta therapy must undergo regular serum liver tests.

GSK now intends to submit a Marketing Authorization Application (MAA) seeking approval for marketing the drug in Europe, where it will be sold under proposed trade name Revolade.

Post new comment

The content of this field is kept private and will not be shown publicly.
 
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.
  • Glossary terms will be automatically marked with links to their descriptions. If there are certain phrases or sections of text that should be excluded from glossary marking and linking, use the special markup, [no-glossary] ... [/no-glossary]. Additionally, these HTML elements will not be scanned: a, abbr, acronym, code, pre.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
For daily updates in your mailbox Subscribe for free via email, or grab our feed.
 

Swine Flu Updates

ppl wearing swine flu masks.jpg

New Delhi, February 4 -- The lethal swine flu influenza shows no sign of abating as new cases of H1N1 related deaths and infections continue to surface every day. With five more lives being snuffed out Wednesday, the death toll in the nation has reached 1,243 so far.

User login

TheMedGuru on Facebook
 
I n   F o c u s
Dull, yellow or stained teeth are a common problem today. Get a sparkling set of white teeth with the help of these tips.
white-teeth.jpg

The major culprits behind dull and stained teeth are tobacco, coffee, cavities, aging, and drugs. While some of the causes of these stains are not in our control, others are.

    Is it H1N1 or just common cold? Here's a little guide for the needy.
    woman sneezing.jpg

    Common cold and seasonal flu are likely to follow the arrival of the winter season. And given that H1N1 strain is also here and even declared a pandemic by World Health Organization (WHO), confusion as to what is it that they are up against abounds among the masses.

      Is there really a G spot? Want to know the truth? Just read on.
      G spot.jpg

      There are a number of different explanations about what the G-spot actually is. Practitioners of tantric sex have been talking about this 'sacred spot' for over 1,000 years.

        R E S O U R C E S I N D US T R Y   N E W S M Y   H E A L T H

        Glossary

        Events & Conferences

        Healthcare Classifieds

        Hospitals Directory

        Forums